keyword
https://read.qxmd.com/read/38590268/electrical-storm-after-left-ventricular-assist-device-lvad-implantation
#1
JOURNAL ARTICLE
Suganya Karikalan, Min Choon Tan, Nan Zhang, Hicham El-Masry, Ammar M Killu, Christopher V DeSimone, Abhishek J Deshmukh, Christopher J McLeod, Dan Sorajja, Komandoor Srivathsan, Luis Scott, Yong-Mei Cha, Justin Z Lee
INTRODUCTION: Ventricular tachycardia storm or electrical storm (ES) is a common complication following left ventricular assist device (LVAD) implantation. The factors contributing to ES and outcomes are less studied. The study aimed to determine the factors associated with ES and the probability of survival in patients undergoing LVAD in three tertiary centers over a span of 15 years. METHODS: We performed a retrospective cohort study on all patients who underwent LVAD implantation at the Mayo Clinic (Rochester, Phoenix, and Jacksonville) from January 1, 2006 to December 31, 2020...
April 9, 2024: Journal of Cardiovascular Electrophysiology
https://read.qxmd.com/read/38560374/left-bundle-branch-pacing-vs-ventricular-septal-pacing-for-cardiac-resynchronization-therapy
#2
JOURNAL ARTICLE
Jingjing Chen, Fatima M Ezzeddine, Xiaoke Liu, Vaibhav Vaidya, Christopher J McLeod, Arturo M Valverde, Freddy Del-Carpio Munoz, Abhishek J Deshmukh, Malini Madhavan, Ammar M Killu, Siva K Mulpuru, Paul A Friedman, Yong-Mei Cha
BACKGROUND: The outcomes of left bundle branch pacing (LBBP) and left ventricular septal pacing (LVSP) in patients with heart failure remain to be learned. OBJECTIVE: The objective of this study was to assess the echocardiographic and clinical outcomes of LBBP, LVSP, and deep septal pacing (DSP). METHODS: This retrospective study included patients who met the criteria for cardiac resynchronization therapy (CRT) and underwent attempted LBBP in 5 Mayo centers...
March 2024: Heart rhythm O2
https://read.qxmd.com/read/38557657/electrocardiography-based-artificial-intelligence-algorithms-aid-in-prediction-of-long-term-mortality-after-kidney-transplantation
#3
JOURNAL ARTICLE
Niv Pencovich, Byron H Smith, Zachi I Attia, Francisco Lopez Jimenez, Andrew J Bentall, Carrie A Schinstock, Hasan A Khamash, Caroline C Jadlowiec, Tambi Jarmi, Shennen A Mao, Walter D Park, Tayyab S Diwan, Paul A Friedman, Mark D Stegall
BACKGROUND: Predicting long-term mortality postkidney transplantation (KT) using baseline clinical data presents significant challenges. This study aims to evaluate the predictive power of artificial intelligence (AI)-enabled analysis of preoperative electrocardiograms (ECGs) in forecasting long-term mortality following KT. METHODS: We analyzed preoperative ECGs from KT recipients at three Mayo Clinic sites (Minnesota, Florida, and Arizona) between January 1, 2006, and July 30, 2021...
April 1, 2024: Transplantation
https://read.qxmd.com/read/38530689/efficacy-of-sacubitril-valsartan-on-survival-and-cardiac-remodeling-in-hypotensive-heart-failure-with-reduced-ejection-fraction-a-multicenter-study
#4
JOURNAL ARTICLE
Chien-Yi Hsu, Fa-Po Chung, Chieh-Ju Chao, Ying-Ju Chen, Cho-Kai Wu, Yen-Wen Wu, Jin-Long Huang, Pao-Hsien Chu, Charles Jia-Yin Hou, Hung-Yu Chang, Chung-Lieh Hung
OBJECTIVE: To investigate whether hypotensive patients diagnosed with heart failure and reduced ejection fraction (HFrEF) might benefit from angiotensin receptor-neprilysin inhibitors (ARNis) in real-world practice because patients with baseline systolic blood pressure (SBP) of less than 100 mm Hg have been excluded from landmark trials. PATIENTS AND METHODS: In this multicenter study conducted between January 1, 2013, and December 31, 2021, a total of 7562 symptomatic patients with HFrEF were enrolled and grouped by SBP (hypotension was defined as an SBP of less than 100 mm Hg) and ARNi use as follows: group 1, hypotensive/non-ARNi users (n=484); group 2, hypotensive/ARNi users (n=308); group 3, nonhypotensive/non-ARNi users (n=4560); and group 4, nonhypotensive/ARNi users (n=2210)...
March 26, 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38486616/fluid-and-salt-balance-are-things-we-often-overlook-could-our-understanding-of-fluid-dynamics-change-how-we-tackle-heart-failure
#5
JOURNAL ARTICLE
Shriya Sharma, Rohan Goswami
No abstract text is available yet for this article.
April 2024: Mayo Clinic Proceedings. Innovations, Quality & Outcomes
https://read.qxmd.com/read/38434935/promise-of-lifestyle-medicine-for-heart-disease-diabetes-mellitus-and-cerebrovascular-diseases
#6
JOURNAL ARTICLE
Aleksandra Pikula, Mahima Gulati, Jonathan P Bonnet, Sarah Ibrahim, Svetlana Chamoun, Andrew M Freeman, Koushik Reddy
The burden of noncommunicable chronic diseases has relevant and negative consequences to persons, health care systems, and economies worldwide. Chronic diseases are the leading cause of disability and mortality and are responsible for 90% of health care expenditure. The most common chronic diseases are diabetes mellitus (DM), cardiovascular disease, and cerebrovascular disease (stroke and vascular cognitive impairment). Modifiable risk factors (MRFs) for these conditions include hypertension, hyperlipidemia, smoking, poor diet, and low-physical activity; with hypertension being the most prevalent MRF...
April 2024: Mayo Clinic Proceedings. Innovations, Quality & Outcomes
https://read.qxmd.com/read/38432746/evolution-and-prognostic-significance-of-patient-reported-symptoms-after-intervention-in-severe-aortic-stenosis
#7
JOURNAL ARTICLE
J Alberto San Román, Cristina Ybarra-Falcón, Mario García-Gómez, Noemí Ramos, Luis Nombela, Manuel Carnero, Ignacio J Amat-Santos, Teresa Sevilla, Ana Revilla, Manuel Carrasco, Javier López-Díaz, Isidre Vilacosta
OBJECTIVE: To describe the evolution of symptoms in patients with symptomatic severe aortic stenosis (sSAS) undergoing valve replacement, the predictors of the persistence of these symptoms, and their prognostic significance. The evolution of symptoms after intervention in sSAS and their association with outcome are unknown. PATIENTS AND METHODS: Data from patients with sSAS who underwent intervention were collected. All-cause mortality and cardiovascular mortality were considered events...
March 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38432741/heart-failure-and-hypertrophic-cardiomyopathy-looking-back-on-decades-of-remarkable-progress
#8
EDITORIAL
Yogesh N V Reddy
No abstract text is available yet for this article.
March 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38390798/predictive-value-of-artificial-intelligence-enabled-electrocardiography-in-patients-with-takotsubo-cardiomyopathy
#9
JOURNAL ARTICLE
Yoshihisa Kanaji, Ilke Ozcan, David N Tryon, Ali Ahmad, Jaskanwal Deep Singh Sara, Brad Lewis, Paul Friedman, Peter A Noseworthy, Lilach O Lerman, Tsunekazu Kakuta, Zachi I Attia, Amir Lerman
BACKGROUND: Recent studies have indicated high rates of future major adverse cardiovascular events in patients with Takotsubo cardiomyopathy (TC), but there is no well-established tool for risk stratification. This study sought to evaluate the prognostic value of several artificial intelligence-augmented ECG (AI-ECG) algorithms in patients with TC. METHODS AND RESULTS: This study examined consecutive patients in the prospective and observational Mayo Clinic Takotsubo syndrome registry...
February 23, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38379633/artificial-intelligence-enabled-electrocardiogram-ai-ecg-does-not-predict-atrial-fibrillation-following-patent-foramen-ovale-closure
#10
JOURNAL ARTICLE
Omar Baqal, Eiad A Habib, Elfatih A Hasabo, Francesca Galasso, Timothy Barry, Reza Arsanjani, John P Sweeney, Peter Noseworthy, F David Fortuin
BACKGROUND: Atrial fibrillation (AF) is a known complication following patent foramen ovale (PFO) closure. AI-enabled ECG (AI-ECG) acquired during normal sinus rhythm has been shown to identify individuals with AF by noting high-risk ECG features invisible to the human eye. We sought to characterize the value of AI-ECG in predicting AF development following PFO closure and investigate key clinical and procedural characteristics possibly associated with post-procedural AF. METHODS: We performed a retrospective analysis of patients who underwent PFO closure at our hospital from January 2011 to December 2022...
April 2024: IJC Heart & Vasculature
https://read.qxmd.com/read/38360558/diagnostic-challenges-between-takotsubo-cardiomyopathy-and-acute-myocardial-infarction-where-is-the-emergency-a-literature-review
#11
REVIEW
Alexandru Scafa-Udriste, Ruxandra-Nicoleta Horodinschi, Miruna Babos, Bogdan Dinu
BACKGROUND: Takotsubo cardiomyopathy (TC) is an emergency cardiovascular disease, with clinical and paraclinical manifestations similar to acute myocardial infarction (AMI), but it is characterized by reversible systolic dysfunction of the left ventricle (LV) in the absence (most of the time) of obstructive coronary artery disease (CAD). MANAGEMENT OF PATIENTS WITH TC: TC seems to be more frequent in post-menopausal women and it is triggered by emotional or physical stress...
February 15, 2024: International Journal of Emergency Medicine
https://read.qxmd.com/read/38348804/association-of-bovine-arch-anatomy-with-incident-stroke-after-transcatheter-aortic-valve-replacement
#12
JOURNAL ARTICLE
Gerardo V Lo Russo, Hasan S Alarouri, Abdulah Al-Abcha, Brennan Vogl, Abdulah Mahayni, Agata Sularz, Hoda Hatoum, Jeremy Collins, Juan A Crestanello, Mohamad Alkhouli
BACKGROUND: Acute ischemic stroke complicates 2% to 3% of transcatheter aortic valve replacements (TAVRs). This study aimed to identify the aortic anatomic correlates in patients after TAVR stroke. METHODS AND RESULTS: This is a single-center, retrospective study of patients who underwent TAVR at the Mayo Clinic between 2012 and 2022. The aortic arch morphology was determined via a manual review of the pre-TAVR computed tomography images. An "a priori" approach was used to select the covariates for the following: (1) the logistic regression model assessing the association between a bovine arch and periprocedural stroke (defined as stroke within 7 days after TAVR); and (2) the Cox proportional hazards regression model assessing the association between a bovine arch and long-term stroke after TAVR...
February 20, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38323938/degree-of-risk-factor-control-and-incident-cardiovascular-diseases-in-patients-with-hypertension
#13
JOURNAL ARTICLE
Minghao Kou, Xuan Wang, Hao Ma, Xiang Li, Yoriko Heianza, Lu Qi
OBJECTIVE: To investigate whether joint risk factor control could reduce the excess risk of cardiovascular disease (CVD) in patients with hypertension. PATIENTS AND METHODS: A total of 75,293 patients with diagnosed hypertension from the UK Biobank study were included, matched with 256,619 nonhypertensive controls, and followed up until May 31, 2021. Seven risk factors were measured to define joint risk factor control, including blood pressure, body mass index, low-density lipoprotein cholesterol, hemoglobin A1c , albuminuria, smoking, and physical activity...
February 5, 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38309937/machine-learning-for-diagnosis-of-pulmonary-hypertension-by-echocardiography
#14
JOURNAL ARTICLE
Vidhu Anand, Alexander D Weston, Christopher G Scott, Garvan C Kane, Patricia A Pellikka, Rickey E Carter
OBJECTIVE: To evaluate a machine learning (ML)-based model for pulmonary hypertension (PH) prediction using measurements and impressions made during echocardiography. METHODS: A total of 7853 consecutive patients with right-sided heart catheterization and transthoracic echocardiography performed within 1 week from January 1, 2012, through December 31, 2019, were included. The data were split into training (n=5024 [64%]), validation (n=1275 [16%]), and testing (n=1554 [20%])...
February 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38309936/temporal-association-between-vaping-and-risk-of-cardiac-events
#15
JOURNAL ARTICLE
Sahej Bains, Ramin Garmany, Raquel Neves, John R Giudicessi, Xiaozhi Gao, David J Tester, J Martijn Bos, Michael J Ackerman
OBJECTIVE: To describe our early observations with sudden cardiac arrest (SCA) and sudden death (SD) in patients using vape products. PATIENTS AND METHODS: A retrospective analysis of Mayo Clinic's Windland Smith Rice Genetic Heart Rhythm Clinic and Sudden Death Genomics Laboratory was performed on all SCA survivors and decedents who presented between January 1, 2007, and December 31, 2021, to identify patients/decedents with a history of vaping. Data abstraction included patient demographics, clinical characteristics, and documented use of vape products...
February 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38304166/the-burden-of-chronic-disease
#16
REVIEW
Karen Hacker
Chronic diseases like diabetes, heart disease, stroke, and cancer have been and continue to be some of the major causes of worldwide morbidity and mortality. A transition between infectious and noncommunicable diseases occurred in the early 1900s as a result of improved public health and has persisted ever since. Now, as individuals live longer, the prevalence and cost of chronic disease continue to grow. The estimated cost of chronic disease is expected to reach $47 trillion worldwide by 2030. Individual lifestyle and behaviors and community factors play important roles in the development and management of chronic diseases...
February 2024: Mayo Clinic Proceedings. Innovations, Quality & Outcomes
https://read.qxmd.com/read/38278491/ten-year-outcomes-post-percutaneous-coronary-intervention-in-cardiac-transplant-recipients
#17
JOURNAL ARTICLE
Vinayak Nagaraja, Bradley R Lewis, Mandeep Singh
BACKGROUND: Cardiac allograft vasculopathy (CAV) is one of the major late causes of mortality in cardiac transplant recipients beyond the first year. Given the lack of longer term data for PCI in cardiac transplant recipients, we report ten year follow up of such cardiac transplant recipients who underwent PCI at Mayo Clinic. METHODS: A retropecitve observational study was conducted that included cardiac transplant recipients who underwent PCI at the Mayo Clinic...
January 24, 2024: International Journal of Cardiology
https://read.qxmd.com/read/38231238/hemodynamics-in-adults-with-systemic-right-ventricles-differences-between-congenitally-corrected-and-complete-transposition-of-the-great-arteries
#18
JOURNAL ARTICLE
William R Miranda, C Charles Jain, Alexander C Egbe, Yogesh N Reddy, Joseph A Dearani, Donald J Hagler, Heidi M Connolly
Despite their anatomical differences, congenitally corrected (ccTGA) and complete transposition of the great arteries (d-TGA) post-atrial switch are frequently studied together and managed similarly from a medical standpoint due to the shared systemic right ventricle (sRV). The aim was to assess differences in their underlying hemodynamics. The study is a retrospective review of 138 adults with ccTGA or d-TGA post-atrial switch undergoing cardiac catheterization at Mayo Clinic, MN between 2000 and 2021...
January 17, 2024: Pediatric Cardiology
https://read.qxmd.com/read/38227797/characteristics-of-normal-weight-insulin-resistant-adults-with-unfavorable-health-outcomes
#19
JOURNAL ARTICLE
Lili Zhang, Adrian Vella, K Sreekumaran Nair, Michael D Jensen
Background: Insulin resistance can be present in otherwise healthy, normal weight adults. Whether there are phenotype/sex-differences between normal weight insulin-resistant (NWIR) and normal weight insulin-sensitive (NWIS) Caucasians and whether there are differences in adverse health outcomes are unknown. Our goal was to define phenotypes and intermediate-term health outcomes of NWIR versus NWIS Caucasian adults. Methods: We analyzed data from 227 healthy volunteers body mass index 18 to <25.0 kg/m2 who underwent insulin clamp studies between January 1987 and January 2017 at Mayo Clinic to identify those in the top (NWIS, n  = 56) and bottom (NWIR, n  = 56) quartiles of insulin action...
January 16, 2024: Metabolic Syndrome and related Disorders
https://read.qxmd.com/read/38180395/cancer-treatment-related-complications-in-patients-with-hypertrophic-cardiomyopathy
#20
JOURNAL ARTICLE
Mattia Zampieri, Stephan A C Schoonvelde, Michele Vinci, Icro Meattini, Luca Visani, Alessandra Fornaro, Raffaele Coppini, Andrea Romei, Alberto Marchi, Ilaria Morelli, Marjon A van Slegtenhorst, Eszter Dalma Palinkas, Lorenzo Livi, Michelle Michels, Iacopo Olivotto
OBJECTIVE: To describe the potential clinical cardiotoxicity of oncological treatments in a cohort of consecutive patients with hypertrophic cardiomyopathy (HCM), systematically followed-up at two national referral centers for HCM. Cardiotoxicity relates to the direct effects of cancer-related treatment on heart function, commonly presenting as left ventricular contractile dysfunction. However, limited data are available regarding cardiotoxic effects on HCM as most studies have not specifically analyzed the effects of oncological treatment in HCM populations...
January 4, 2024: Mayo Clinic Proceedings
keyword
keyword
91873
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.